Table 2.
Immunophenotypic features of canine mammary neoplasms.
| Mixed tumour subtype | COX2 (score =/> 6) | Ki67 | HER2 | Oestrogen receptor | Progesterone receptor | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (+) | (−) | NA | >20% | <20% | NA | (+) | (−) | NA | (+) | (−) | NA | (+) | (−) | NA | |
| BMT | 0 | 11 | 4 | 0 | 13 | 2 | 0 | 13 | 2 | 13 | 0 | 2 | 13 | 0 | 2 |
| CMT | 4 | 10 | 2 | 1 | 12 | 2 | 0 | 14 | 1 | 13 | 0 | 2 | 13 | 0 | 2 |
| CMTM | 2 | 12 | 1 | 4 | 10 | 1 | 0 | 13 | 2 | 12 | 2 | 1 | 12 | 2 | 1 |
Benign mixed tumour (BMT), carcinoma in mixed tumour without metastasis (CMT), carcinoma in mixed tumour with metastasis (CMTM). HER2: human epidermal growth factor receptor 2. (+) = positive. (−) = negative. NA was not evaluated.